We asked a range of industry experts to comment about critical business, regulatory, science, and market trends that warrant industry focus, and to anticipate key developments for the coming year. Common threads in their responses included the impact of tariff and trade policies, state regulations, AI, new research directions, trending health markets, innovation, and a host of emerging opportunities.

This main hub page serves as your gateway to our series, which features perspectives from top executives and thought leaders across the industry. Each piece offers actionable takeaways, unique forecasts, and thought-provoking commentary — whether you’re focused on regulatory shifts, scientific innovation, or market trends.

We’ll be updating this page as we roll out more content from this series in coming days and weeks. Stay up to date with all our content by becoming a subscriber.

Featured Expert Insights

Graham Rigby, President & CEO, American Herbal Products Association (AHPA)

The herbal supplements market is growing, consumer priorities are evolving, and key regulatory and policy developments are shaping the future of responsible commerce and innovation. Read Graham’s insights >>

---

Duffy MacKay, Senior Vice President of Dietary Supplements, Consumer Healthcare Products Association (CHPA)

Ingredient safety is shifting from a regulatory requirement to a market-driven standard, as transparency, documentation, and risk management become defining factors. Read Duffy’s insights >>

---

Steve Mister, President & CEO, Council for Responsible Nutrition (CRN)

The supplement industry is leading the shift from reactive to proactive healthcare goals while advancing responsible self-regulation, strengthening consumer trust, and ensuring access through science-based advocacy and transparency. Read Steve’s insights >>

---

Kyle Turk, VP of Government Affairs, Natural Products Association (NPA)

Escalating state-level regulations threaten consumer access and the federal framework governing dietary supplements. Read Kyle’s insights >>

---

Karen Howard, CEO, Executive Director, Organic & Natural Health Association

Healthcare reform, tariffs, and emerging technologies like AI are reshaping the supplement industry. Read Karen’s insights >>

---

Loren Israelsen, Founder and President of the United Natural Products Alliance (UNPA)

Tariffs, supply chain volatility, ingredient safety, and evolving state and federal regulations are among the key issues to watch. Read Loren’s insights >>

---

Shaheen Majeed, Global CEO and Managing Director, Sabinsa

Supply challenges, market volatility, and emerging science are impacting nutraceutical innovation. Read Shaheen’s insights >>

---

Ellen Schutt, Managing Director, Global Organization for EPA and DHA Omega-3s (GOED)

Tariffs, inflation, and raw material shortages are reshaping the omega-3 supply chain reinforcing the need for diversified EPA and DHA sources to maintain stability and ensure long-term category growth. Read Ellen’s insights >>

---

Ivan Wasserman, Managing Partner, Amin Wasserman Gurnani

The regulatory landscape of the supplement industry is shifting. Expect new federal rules on GRAS notifications, increased state activity, and potential resurgence in enforcement from the FTC and state attorneys general. Read Ivan’s insights >>

---

Asa Waldstein, Principal, Apex Compliance

Learn about emerging enforcement trends shaping supplement marketing and GMP compliance, including FDA focus on documentation and identity testing, and increased scrutiny of online claims. Read Asa’s insights >>

---

Beth Lambert, CEO, Herbalist & Alchemist

Uncertainty around the timing, application, adjustment, and future of tariffs continues to raise many questions for the botanical industry. Read Beth’s insights >>

---

Kenn Israel, Co-Founding Partner and Nutrition Practice Leader, Beyond Brands

High tariffs and trade policy instability have caused significant disruption in supply chain relationships and capital projects. Read Kenn’s insights >>

---

Heather Granato, President, Nutrachievement Inc., and President, Women In Nutraceuticals (WIN)

There’s growing momentum in women’s health research and plenty of opportunities for companies to develop unique, more personalized supplement formulations. Read Heather’s insights >>

---

Sheldon Baker, CEO, Baker Dillon Group

AI is transforming supplement research and development, and brands continue to innovate with new delivery formats beyond traditional capsules and tablets. Read Sheldon’s insights >>

---

Douglas Kalman and Susan Hewlings, Co-Founders, Substantiation Sciences

The shift toward scalable, virtual RCTs and AI-supported analytics is one of the most important trends to watch.

Read Doug and Susan’s insights >>

---

Pelin Thorogood, Co-Founder & Executive Chairwoman, and Jeff Chen, MD, Co-Founder and CEO, Radicle Science

The scientific and business communities have recognized that decentralized trials broaden diverse participation and generate evidence that is more generalizable and real-world. 

Read Pelin and Jeff’s insights >>

---

Len Monheit, Executive Director of the Global Prebiotic Association and CEO of Industry Transparency Center,

Healthspan, the microbiome, women’s health, prebiotics and GLP-1 support present sizable market opportunities. Read Len’s insights >>

---

Suzanne Shelton, Founder, The Shelton Group

Suppliers and brands are working even more closely with each other to mitigate the effects of tariffs and uncertainty. Read Suzanne’s insights >>

---

Todd Spear, VP of Sales & Marketing, Protein Research

Despite the headwinds, there is an intense focus on new product development with innovative new ingredients. Read Todd’s insights >>

---

Terese Mansell, Vice President, Nutrients Division, Kaneka North America

As the supplement market advances, new regulatory pressures mount, and scientific advances in cognition, gut health, and longevity will have lasting impact. Read Terese’s insights >>

---

Steve Fink, Vice President, Marketing, PLT Health Solutions

With new consumers, new channels, new attitudes and new technology, innovation isn’t just a market orientation anymore — it’s our product. Read Steve’s insights >>

---

Eric Anderson, Managing Director, NXT USA:

Finally — the industry is beginning to innovate again. We’re coming out of the Covid desert. What’s driving all this innovation? Let me count the ways. Read Eric’s insights here >>

---

Cal Bewicke, CEO, Ethical Naturals Inc (ENI)

Long-term planning and strategic partnerships that put quality first will help companies navigate tariff pressures, climate disruptions, and growing demand for clinically validated, branded ingredients. Read Cal’s insights here >>

---

Elan Sudberg, CEO, Alkemist Labs

Transparency, accountability, and AI-driven innovation are reshaping quality standards and driving a new era of trust in the supplement industry. Read Elan’s insights here >>

---

Bill Chioffi, COO, Nammex

Advancing analytical standards for fungal ingredients will build greater transparency and trust at a time of increased regulatory scrutiny. Read Bill’s insights here >>

---

Wilson Lau, President, Nuherbs

Tariff complexities, sustainability initiatives, and the booming functional beverage market are driving greater collaboration and accountability across the botanical supply chain. Read Wilson’s insights here >>

---

Annemarie Halter, VP Health Ingredients, Lallemand Bio-Ingredients

In an era of instability and skepticism, transparency, safety, and scientific validation are essential to building lasting consumer confidence. Read Annemarie’s insights here >>

---

Catherine Nardone, VP Marketing, Concordix (Vitux)

Evolving consumer health needs and shifting expectations are driving innovation in supplement formulation and delivery. Read Catherine’s insights here >>

---

Simo Echchafai, SVP Human Health Ingredients North America, Aker BioMarine

The convergence of weight management, cognitive performance, and sustainability is driving a more science-led, responsible future for the nutraceutical industry. Read Simo’s insights here >>

---